Lombard Medical Technologies (LSE:LMT) EBITDA Margin % : -206.92% (As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lombard Medical Technologies's EBITDA for the six months ended in Dec. 2012 was £-8.05 Mil. Lombard Medical Technologies's Revenue for the six months ended in Dec. 2012 was £3.89 Mil. Therefore, Lombard Medical Technologies's EBITDA margin for the quarter that ended in Dec. 2012 was -206.92%.

Lombard Medical Technologies EBITDA Margin % Historical Data

The historical data trend for Lombard Medical Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies EBITDA Margin % Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

EBITDA Margin %

Get a 7-Day Free Trial

-588.18

-319.64

-286.86

-281.72

-206.92

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
EBITDA Margin %	Get a 7-Day Free Trial					-588.18	-319.64	-286.86	-281.72	-206.92

Competitive Comparison of Lombard Medical Technologies's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lombard Medical Technologies's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's EBITDA Margin % falls into.

Lombard Medical Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Lombard Medical Technologies's EBITDA Margin % for the fiscal year that ended in Dec. 2012 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2012 )	/	Revenue (A: Dec. 2012 )
	=	-8.049	/	3.89
	=	-206.92 %

Lombard Medical Technologies's EBITDA Margin % for the quarter that ended in Dec. 2012 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2012 )	/	Revenue (Q: Dec. 2012 )
	=	-8.049	/	3.89
	=	-206.92 %

Lombard Medical Technologies (LSE:LMT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Lombard Medical Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.